1. Home
  2. IMMP vs ONMD Comparison

IMMP vs ONMD Comparison

Compare IMMP & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immutep Limited

IMMP

Immutep Limited

SELL

Current Price

$3.36

Market Cap

31.5M

Sector

Health Care

ML Signal

SELL

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$4.80

Market Cap

31.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMMP
ONMD
Founded
1987
2006
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.5M
31.3M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
IMMP
ONMD
Price
$3.36
$4.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 30.6K
21.5K
Earning Date
09-01-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 83.33
EPS
★ N/A
N/A
Revenue
N/A
★ $1,359,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 111.35
52 Week Low
$0.26
$0.63
52 Week High
$5.36
$115.00

Technical Indicators

Market Signals
Indicator
IMMP
ONMD
Relative Strength Index (RSI) 49.75 37.47
Support Level $3.06 $3.86
Resistance Level $3.55 $4.99
Average True Range (ATR) 0.34 0.57
MACD -0.05 0.37
Stochastic Oscillator 41.09 22.66

Price Performance

Historical Comparison
IMMP
ONMD

About IMMP Immutep Limited

Immutep Ltd is a clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

Share on Social Networks: